GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Healthcare professionals recognize virtual care role in empowering patients, reveals GlobalData

As digital health technologies continue to evolve, healthcare professionals (HCPs) are increasingly recognizing the role of virtual care in empowering patients. Against this backdrop, a significant majority of HCPs believe trends like telemedicine and remote care have given patients more control over their health management, underscoring the growing importance of virtual care in modern healthcare, […]
Read more

Sanofi and Regeneron AIM4 trial may redefine timing of biologic use in asthma care, says GlobalData

Sanofi and Regeneron Pharmaceuticals (Regeneron) have launched the Phase IIIb/IV AIM4 trial at the 2025 American Thoracic Society (ATS) International Conference to evaluate whether earlier initiation of dupilumab improves outcomes in patients with moderate-to-severe asthma compared to standard stepwise escalation with high-dose inhaled corticosteroids. The study reflects a growing shift toward personalized, biomarker-driven asthma management […]
Read more

Cautious investor sentiment pulls global deal activity down 5% YoY in first four months of 2025, finds GlobalData

Cautious investor sentiment has weighed heavily on the global deal landscape, with mergers and acquisitions, private equity, and venture financing activities collectively declining by approximately 5% year-on-year (YoY) during the first four months of 2025. Geopolitical uncertainty and macroeconomic headwinds have prompted dealmakers to adopt a more selective, risk-averse approach, leading to a slowdown across […]
Read more

Revolut’s EUR1 billion investment in France raises concerns over UK FinTech competitiveness, says GlobalData

Following the news that London-based FinTech giant Revolut Ltd plans to invest EUR1 billion in France and relocate its Western European headquarters to Paris; Harry Swain, Banking and Payments Analyst at GlobalData, a leading data and analytics company, offers his view: “Revolut’s shift towards a dual-headquarter model in Paris and Vilnius speaks volumes about the […]
Read more

Real-world data backs anti-IL-5 use in COPD with comorbid asthma, says GlobalData

Anti–IL-5 biologics, such as mepolizumab and benralizumab, have demonstrated significant efficacy in reducing moderate and severe exacerbations in patients with both asthma and chronic obstructive pulmonary disease (COPD), according to new real-world data presented at the 2025 American Thoracic Society (ATS) International Conference. These findings reinforce the therapeutic potential of eosinophil-targeting agents in patients with […]
Read more

GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients, says GlobalData

GSK’s Nucala (mepolizumab) demonstrated a consistent reduction in exacerbation rates among patients with eosinophilic chronic obstructive pulmonary disease (COPD), irrespective of prior severe event history, according to findings presented at the 2025 American Thoracic Society (ATS) International Conference. These results further solidify the role of IL-5 inhibition in biomarker-driven COPD management, says GlobalData, a leading […]
Read more

Indonesia credit and charge card payments market to grow by 3.2% in 2025, forecasts GlobalData

Indonesia’s credit and charge card payments market is expected to register a growth of 3.2% to reach IDR441.8 trillion ($27.9 billion) in 2025. This growth will be driven by the rising consumer spending and increasing consumer preference for cashless transactions. Enhanced by value-added incentives such as cashback offers, flexible repayment options, and installment facilities, the […]
Read more

HIV market to surpass $32 billion across 7MM in 2033, forecasts GlobalData

The human immunodeficiency virus (HIV) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 1.9% from $26.5 billion in 2023 to $32.1 billion in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast,” reveals that market […]
Read more

US anesthesia and respiratory devices market faces disruption as tariffs drive supply chain shift, says GlobalData

The US anesthesia and respiratory (A&R) devices market faces major disruption as new US tariffs hit foreign-made products, with majority of all 510(k) approved devices manufactured outside the country. This raises serious supply chain concerns and may shift market dynamics in favor of domestic manufacturers, even as the market grows from $4.4 billion in 2023 […]
Read more

Italy card payments to hit $443.7 billion in 2025 despite economic headwinds, forecasts GlobalData

The Italy card payments market is expected to grow by 6.6% to reach EUR410.2 billion ($443.7 billion) in 2025 despite global economic uncertainty. This reflects rising consumer preference for electronic payments, supported by government policies, increased contactless adoption, and a shift towards digital banking, according to GlobalData, a leading data and analytics company. GlobalData’s Payment […]
Read more

Top 25 global banks post 9.4% revenue growth YoY in 2024 but profits under pressure, reveals GlobalData

The world’s top 25 global banks reported 9.4% year-on-year (YoY) revenue growth in 2024 despite global economic pressures, with Sberbank Rossii, BBVA, and UBS Group standing out as key performers. However, profit margins were mixed, as many banks faced higher costs, regulatory tightening, and geopolitical uncertainty, highlighting the growing gap between revenue performance and overall […]
Read more

Australia card acquiring market to hit $700 billion in 2025 as growth set to slow amid global uncertainty, says GlobalData

The Australian card acquiring market is projected to grow by 5.5% to reach AUD1.1 trillion ($713.4 billion) in 2025. Despite this growth, global economic uncertainty linked to recent US tariffs may weigh on momentum, slowing the pace of expansion compared to previous years of stronger performance driven by cashless trends and consumer spending, according to […]
Read more

South Africa card payments to exceed $158 billion in 2025 amid digital surge and inclusion push, forecasts GlobalData

The South African card payments market is on a solid growth trajectory, projected to reach ZAR2.9 trillion ($158.8 billion) in 2025. This momentum is driven by a growing shift toward digital payments, bolstered by enhanced financial inclusion, expanding payment infrastructure, and rising consumer preference for speed, safety, and convenience in everyday transactions, says GlobalData, a […]
Read more

GLP-1R agonists poised to redefine chronic disease treatment beyond diabetes and obesity, says GlobalData

GLP-1 receptor agonists, once focused on treating diabetes and obesity, are now emerging as potential treatments for a broader range of chronic conditions, including Alzheimer’s disease. As evidence builds around their wider therapeutic benefits, particularly in targeting insulin resistance, drug developers are accelerating efforts to expand their use and potentially transform how multiple high-burden diseases […]
Read more

GlobalData unveils strategies to decarbonize artificial intelligence

The accelerating adoption of artificial intelligence (AI) is driving up energy consumption and greenhouse gas (GHG) emissions across the AI value chain, raising urgent concerns about its long-term sustainability and the environmental impact on tech giants. In response, new research outlines key strategies to decarbonize AI, focusing on improvements in energy sourcing, data center infrastructure, […]
Read more

Private labels surge as US consumers prioritize value amid inflation and tariff uncertainty, says GlobalData

Following the underwhelming Q1 2025 results from several major US food manufacturers, driven in part by tariff uncertainties dampening consumer spending; Hannah Cleland, Senior Consumer Analyst at GlobalData, a leading data and analytics company, offers her view: “The ongoing inflationary pressures in the US have driven consumers to prioritize affordability, fuelling a marked rise in […]
Read more
1 27 28 29 30 31 206